VHCP Management III’s Prevail Therapeutics PRVL Stock Holding History
Bought
Maintained
Sold
Other funds holding PRVL
VHCP Management III's PRVL Position: Q4 2019 in Review
VHCP Management III sold out of Prevail Therapeutics (PRVL) in Q4 2019, closing a stake of 4,408 shares — an estimated $54K sold.
VHCP Management III first reported a position in PRVL in Q3 2019 and held it in 1 quarter. The position peaked at $54K in Q3 2019. 46 funds tracked by Wall St. Rank hold PRVL as of Q4 2019.
- VHCP Management III reported no remaining Prevail Therapeutics position as of Q4 2019 after selling out during the quarter.
- VHCP Management III sold 4,408 Prevail Therapeutics shares in Q4 2019, an estimated $54K.
- VHCP Management III first reported a position in Prevail Therapeutics in Q3 2019 and held it in 1 quarter.
- VHCP Management III's Prevail Therapeutics position peaked at $54K in Q3 2019.
- 46 funds tracked by Wall St. Rank held Prevail Therapeutics as of Q4 2019.
Based on VHCP Management III's 13F filing for Q4 2019, filed 13 Feb 2020.